Dr. Felix Sheinerman, PhD is a co-founder and Chief Scientific Officer at nPharmakon LLC, a life sciences company focused on the identification of previously unknown molecular targets of clinically tested drugs and the development of the drugs for new uses. Prior to his joining nPharmakon, Felix served as Head of Chemogenomics Group, Chemistry at sanofi-aventis, and before that, as Principal Investigator, Informatics at Aventis. Felix completed Alfred P. Sloan Foundation Fellowship in Computational Biology at Columbia University, New York, NY, studying ligand-binding preferences of members of large protein families, and received PhD in Molecular and Cellular Structure and Chemistry from The Scripps Research Institute, La Jolla, CA, working on the protein folding problem.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)